Aurenar: Funding, Investors & Team (Oct 2026)
Aurenar develops non-invasive neuromodulation devices to modulate inflammation and support intensive care patients.
Aurenar has raised $5.7M across 1 funding round on record, the most recent a Seed of $5.7M announced in Jul 2026.
That round is below the $7.6M median round size for United States companies tracked on FundedIQ over the last two years.
Aurenar Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Aurenar Funding Rounds
Aurenar Investors
Aurenar Funding in Context
Aurenar's latest round of $5.7M is below the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aurenar in Clinical Trials and St Louis
Companies Similar to Aurenar
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Hone creates AI agents that can help run a business, joining a crowded field of services using the technology…
Sonilo provides an AI video-to-music platform that generates synchronized, commercially usable soundtracks…
PlotPicks is an interactive entertainment platform that combines television viewing with prediction-based…
Negosh operates a data-driven platform and marketplace that connects brand owners with manufacturers and…
Insuraviews provides software for analyzing insurance rate filings with search, analytics, and competitive…
Thrixel is an AI-powered 3D model generation platform designed to integrate directly with coding agents, AI…
Vye Health is an AI-native healthcare company that provides tools for medical providers to launch and run…
Park Golf Pitch & Putt is a sports company that focuses on outdoor entertainment with focus on pitch-putt…
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Voltus represents the "potential of us" to better manage energy through simple, cost and risk-free…
Aurenar Funding FAQs
What does Aurenar do?
Aurenar develops non-invasive neuromodulation devices to modulate inflammation and support intensive care patients.
How much funding has Aurenar raised?
Aurenar has raised $5.7M across 1 round on record. The most recent is a Seed of $5.7M announced in Jul 2026.
When did Aurenar last raise funding?
Aurenar's most recent funding round on record is a Seed of $5.7M, announced in Jul 2026.
Who has invested in Aurenar?
Investors on record for Aurenar include Solas BioVentures, Kaleida Capital, American Heart Association Ventures, BJC HealthCare.
Where is Aurenar headquartered?
Aurenar is based in St Louis, United States.
How many employees does Aurenar have?
Aurenar is in the 1-10 employee band.
About FundedIQ's Aurenar Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aurenar is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.